Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Saved in:
| Title: | Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms. |
|---|---|
| Authors: | Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Perez MAS; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Schmidt J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Lozano-Rabella M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Sauvage C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Saugy D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Michel A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Huguenin-Bergenat AL; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Capt C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Moore JS; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland., De Vito C; Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Labidi-Galy SI; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Oliveira G; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu CJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Zoete V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch. |
| Source: | Nature biotechnology [Nat Biotechnol] 2025 Mar; Vol. 43 (3), pp. 445. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38918618 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pétremand+R%22">Pétremand R</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chiffelle+J%22">Chiffelle J</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bobisse+S%22">Bobisse S</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Perez+MAS%22">Perez MAS</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schmidt+J%22">Schmidt J</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Arnaud+M%22">Arnaud M</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Barras+D%22">Barras D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lozano-Rabella+M%22">Lozano-Rabella M</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Genolet+R%22">Genolet R</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sauvage+C%22">Sauvage C</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Saugy+D%22">Saugy D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Michel+A%22">Michel A</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Huguenin-Bergenat+AL%22">Huguenin-Bergenat AL</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Capt+C%22">Capt C</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Moore+JS%22">Moore JS</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22De+Vito+C%22">De Vito C</searchLink>; Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+SI%22">Labidi-Galy SI</searchLink>; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kandalaft+LE%22">Kandalaft LE</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dangaj+Laniti+D%22">Dangaj Laniti D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bassani-Sternberg+M%22">Bassani-Sternberg M</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oliveira+G%22">Oliveira G</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+CJ%22">Wu CJ</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Coukos+G%22">Coukos G</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zoete+V%22">Zoete V</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Harari+A%22">Harari A</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229604648%22">Nature biotechnology</searchLink> [Nat Biotechnol] 2025 Mar; Vol. 43 (3), pp. 445. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Publishing%22">Nature America Publishing </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9604648 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1696 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210870156%22">10870156 </searchLink><i>NLM ISO Abbreviation: </i>Nat Biotechnol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38918618 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41587-024-02318-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 445 Titles: – TitleFull: Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pétremand R – PersonEntity: Name: NameFull: Chiffelle J – PersonEntity: Name: NameFull: Bobisse S – PersonEntity: Name: NameFull: Perez MAS – PersonEntity: Name: NameFull: Schmidt J – PersonEntity: Name: NameFull: Arnaud M – PersonEntity: Name: NameFull: Barras D – PersonEntity: Name: NameFull: Lozano-Rabella M – PersonEntity: Name: NameFull: Genolet R – PersonEntity: Name: NameFull: Sauvage C – PersonEntity: Name: NameFull: Saugy D – PersonEntity: Name: NameFull: Michel A – PersonEntity: Name: NameFull: Huguenin-Bergenat AL – PersonEntity: Name: NameFull: Capt C – PersonEntity: Name: NameFull: Moore JS – PersonEntity: Name: NameFull: De Vito C – PersonEntity: Name: NameFull: Labidi-Galy SI – PersonEntity: Name: NameFull: Kandalaft LE – PersonEntity: Name: NameFull: Dangaj Laniti D – PersonEntity: Name: NameFull: Bassani-Sternberg M – PersonEntity: Name: NameFull: Oliveira G – PersonEntity: Name: NameFull: Wu CJ – PersonEntity: Name: NameFull: Coukos G – PersonEntity: Name: NameFull: Zoete V – PersonEntity: Name: NameFull: Harari A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1546-1696 Numbering: – Type: volume Value: 43 – Type: issue Value: 3 Titles: – TitleFull: Nature biotechnology Type: main |
| ResultId | 1 |